Published in Scand J Gastroenterol on September 01, 2003
Health-related Quality of Life in Patients at Nordic Clinic | NCT04611074
A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut (2013) 3.14
Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention. Aliment Pharmacol Ther (2012) 1.47
Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life. World J Gastroenterol (2004) 1.20
Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS). BMC Gastroenterol (2007) 1.10
Patient-reported outcomes in gastroenterology: clinical and research applications. J Neurogastroenterol Motil (2013) 1.07
Qualitative development of a patient-reported outcome symptom measure in diarrhea-predominant irritable bowel syndrome. Clin Transl Gastroenterol (2014) 1.07
Evaluation of the Birmingham IBS symptom questionnaire. BMC Gastroenterol (2008) 1.06
A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency. Am J Gastroenterol (2016) 0.98
Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterol (2011) 0.97
Health-related quality of life of irritable bowel syndrome patients in different cultural settings. Health Qual Life Outcomes (2006) 0.95
Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1. Arch Neurol (2010) 0.85
Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database. Am J Gastroenterol (2013) 0.80
Bloating and functional gastro-intestinal disorders: where are we and where are we going? World J Gastroenterol (2014) 0.80
Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial. J Neurogastroenterol Motil (2017) 0.78
The Gastrointestinal Pain Pointer: A Valid and Innovative Method to Assess Gastrointestinal Symptoms. Gastroenterol Nurs (2015) 0.78
The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS). Neurogastroenterol Motil (2016) 0.77
Sacral nerve stimulation for faecal incontinence - efficacy confirmed from a two-centre prospectively maintained database. Int J Colorectal Dis (2015) 0.76
Prediction of symptomatic improvement after exposure-based treatment for irritable bowel syndrome. BMC Gastroenterol (2013) 0.76
Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes (2012) 0.76
Health related quality of life in irritable bowel syndrome patients, Kashan, Iran: A case control study. Adv Biomed Res (2015) 0.76
A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) Study. Contemp Clin Trials (2016) 0.75
Using best practice to create a pathway to improve management of irritable bowel syndrome: aiming for timely diagnosis, effective treatment and equitable care. Frontline Gastroenterol (2016) 0.75
A mixed methods feasibility study to evaluate the use of a low-intensity, nurse-delivered cognitive behavioural therapy for the treatment of irritable bowel syndrome. BMJ Open (2014) 0.75
Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls. BMC Gastroenterol (2016) 0.75
Association between gastrointestinal symptoms and affectivity in patients with bipolar disorder. World J Gastroenterol (2016) 0.75
Hypothalamus-Pituitary-Adrenal Axis Hypersuppression Is Associated with Gastrointestinal Symptoms in Major Depression. J Neurogastroenterol Motil (2016) 0.75
Effect of body mass index and intra-abdominal fat measured by computed tomography on the risk of bowel symptoms. PLoS One (2015) 0.75
Effect of Colostrum on the Symptoms and Mucosal Permeability in Patients with Irritable Bowel Syndrome: A Randomized Placebo-controlled Study. Intest Res (2014) 0.75
Internet-Delivered Cognitive Behavior Therapy for Adolescents With Irritable Bowel Syndrome: A Randomized Controlled Trial. Am J Gastroenterol (2016) 0.75
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med (2001) 11.56
Functional bowel disorders and functional abdominal pain. Gut (1999) 7.63
The use of chaperones by general practitioners. J R Coll Gen Pract (1983) 7.27
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med (1998) 3.96
Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology (1995) 3.95
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med (2000) 3.71
Irritable bowel syndrome: a multibillion-dollar problem. Gastroenterology (1995) 3.58
The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology (2000) 3.25
Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ (1992) 3.17
Assessing the impact of total quality management and organizational culture on multiple outcomes of care for coronary artery bypass graft surgery patients. Med Care (2000) 3.17
Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? Gastroenterology (1985) 3.12
A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med (2001) 3.05
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int (1992) 2.89
Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut (1997) 2.77
Ventilatory capacity in young adults with a history of asthma in childhood. Br Med J (1966) 2.76
Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network. J Am Coll Cardiol (2000) 2.67
Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences. Ann Intern Med (1997) 2.60
Measurement of gastric functions during digestion of ordinary solid meals in man. Gastroenterology (1976) 2.56
Cyclic vomiting syndrome in adults. Neurogastroenterol Motil (2008) 2.40
Predictors of mortality for patients undergoing cardiac valve replacements in New York State. Ann Thorac Surg (2000) 2.39
Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology (1994) 2.39
Demonstration of extracellular material at the surface of pathogenic T. pallidum cells. Br J Vener Dis (1976) 2.39
Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology (1997) 2.39
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med (1996) 2.37
The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. JAMA (1989) 2.33
Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther (2013) 2.26
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet (1993) 2.20
Lymphocyte transformation in syphilis: an in vitro correlate of immune suppression in vivo? Infect Immun (1975) 2.17
Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A (1997) 2.12
Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am J Physiol Gastrointest Liver Physiol (2002) 2.10
Stimulus and site specific induction of hiccups in the oesophagus of normal subjects. Gut (1997) 2.10
Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy. Lancet (1993) 2.10
Growth and subculture of pathogenic T. pallidum (Nichols strain) in BHK-21 cultured tissue cells. Br J Vener Dis (1976) 2.05
Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection. BMJ (1994) 1.99
Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil (2007) 1.98
General practitioners' views about the statutory annual practice report. BMJ (1994) 1.97
Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain (2000) 1.97
Sleep disturbances in clinic patients with functional bowel disorders. Am J Gastroenterol (2000) 1.96
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ (1992) 1.94
Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology (1997) 1.94
Prescribing in the UK. Lancet (2001) 1.93
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation (1994) 1.91
Journals should see original protocols for clinical trials. BMJ (2001) 1.88
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
Mediastinitis after coronary artery bypass graft surgery. Risk factors and long-term survival. Circulation (1995) 1.82
The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther (2004) 1.76
Management of cardiac arrest in the community: a survey of resuscitation services. Br Med J (Clin Res Ed) (1983) 1.74
Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders. Drugs (1998) 1.74
Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics. Am J Gastroenterol (2003) 1.73
Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am J Physiol (1997) 1.70
Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology (1998) 1.70
Overwintering mechanism for bluetongue virus: biological recovery of latent virus from a bovine by bites of Culicoides variipennis. Am J Trop Med Hyg (1977) 1.69
Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J Clin Microbiol (1999) 1.69
Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther (1999) 1.66
Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patients. Lancet (1982) 1.64
Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med (2001) 1.64
Abdominal pain caused by diabetic radiculopathy. Ann Intern Med (1977) 1.63
Treatment of acute otitis media: a controlled study of 142 children. Can Med Assoc J (1970) 1.62
Effect of age on the response of the left ventricular ejection fraction to exercise. N Engl J Med (1980) 1.61
Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variables. Circulation (1990) 1.61
Proactive integrated care improves quality of life in patients with COPD. Eur Respir J (2009) 1.61
Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology (1997) 1.59
High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut (1991) 1.58
Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain. Neurogastroenterol Motil (2009) 1.58
Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut (1998) 1.57
Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol (2001) 1.57
Esophageal tear caused by a tortilla chip. N Engl J Med (1990) 1.56
Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome. Arch Intern Med (2001) 1.55
Two dimensional echocardiography in mitral, aortic and tricuspid valve prolapse. The clinical problem, cardiac nuclear imaging considerations and a proposed standard for diagnosis. Am J Cardiol (1980) 1.55
Comparison of medicine alone, coronary angioplasty, and left internal mammary artery-coronary artery bypass for one-vessel proximal left anterior descending coronary artery disease. Am J Cardiol (2000) 1.54
Estradiol inhibits atp-induced intracellular calcium concentration increase in dorsal root ganglia neurons. Neuroscience (2003) 1.53
Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci (Lond) (1992) 1.53
Gastric secretion and emptying after ordinary meals in duodenal ulcer. Gastroenterology (1977) 1.51
Improving power with repeated measures: diet and serum lipids. Am J Clin Nutr (1998) 1.50
Bluetongue in cattle: effects of Culicoides variipennis-transmitted bluetongue virus on pregnant heifers and their calves. Am J Vet Res (1977) 1.49
Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol (1999) 1.49
Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther (2010) 1.48
Symptoms and visceral perception in severe functional and organic dyspepsia. Gut (1998) 1.48
Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention. Aliment Pharmacol Ther (2012) 1.47
A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Scand J Gastroenterol (1987) 1.47
Gender-related differences in IBS symptoms. Am J Gastroenterol (2001) 1.47
A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol (1986) 1.46
Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Aliment Pharmacol Ther (1997) 1.45
Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease. Scand J Gastroenterol (1984) 1.44
Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis. Endoscopy (2010) 1.44
Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis. Neuroimage (2008) 1.43
Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta3. Am J Physiol (1999) 1.42
CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in rats. Gut (2005) 1.41
Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil (2008) 1.41